Enisamium is an inhibitor of the SARS-CoV-2 RNA polymerase and shows improvement of recovery in COVID-19 patients in an interim analysis of a clinical trial.
Holubovska O, Bojkova D, Elli S, Bechtel M, Boltz D, Muzzio M, Peng X, Sala F, Cosentino C, Mironenko A, Milde J, Lebed Y, Stammer H, Goy A, Guerrini M, Mueller L, Cinatl J, Margitich V, Te Velthuis AJW.
Holubovska O, et al. Among authors: milde j.
medRxiv [Preprint]. 2021 Jan 21:2021.01.05.21249237. doi: 10.1101/2021.01.05.21249237.
medRxiv. 2021.
PMID: 33469600
Free PMC article.
Updated.
Preprint.